Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8497247
APP PUB NO 20120258094A1
SERIAL NO

13404384

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compositions and methods for treating autoimmune diseases, such as diabetes, by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BRISTOL-MYERS SQUIBB COMPANY

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Becker, Jean-Claude Princeton, US 12 180
Carr, Suzette Hopewell, US 5 172
Cohen, Robert Newtown, US 63 2332
Hagerty, David Cardiff by the Sea, US 11 220
Peach, Robert James San Diego, US 32 363

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 30, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00